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Abstract. Pathological amounts of carcinoembryonic anti- 
gen (CEA) have earlier been reported in the plasma of pa- 
tients with retinoblastoma, nd it has been suggested that 
CEA determinations be used in the follow-up of treatment 
of these patients. In the present study, 47 retinoblastoma 
specimens from the years 1962-1982 were examined. These 
specimens represented different clinical and pathological tu- 
mour types. Colon adenocarcinomata positive for CEA 
were used as controls. The laboratory method was a highly 
sensitive immunohistochemical peroxidase-staining proce- 
dure. By this method, CEA was not found in any of the 
retinoblastomata examined. It is probable that retinoblas- 
toma does not produce CEA, but in theory it may indirectly 
increase the CEA titre or, on the other hand, be fully inde- 
pendent of CEA. Only after this relationship has been 
thoroughly clarified can determinations of plasma CEA in 
patients with retinoblastoma be used in clinical work. 
Introduction 
Carcinoembryonic antigen (CEA) was first described by 
Gold and Freedman (1965a and b) as an oncofoetal glyco- 
protein of the human gastrointestinal tract. It is a structur- 
ally heterogeneous peripheral membrane protein which can 
be found in the blood circulation as well (Rogers 1976). 
Subsequently, CEA has also been demonstrated in healthy 
adults and in connection with numerous malignant and be- 
nign disorders, and there is no general agreement as to 
its possible clinical applications (Anonymous 1981). Deter- 
minations of plasma CEA titre have mostly been used for 
the post-operative follow-up of patients with adenocarcino- 
ma of the colon (yon Kleist 1977; Anonymous 1981). 
Elevated plasma CEA titre has been associated with 
several intraocular metastases (Michelson etal. 1976a, 
1977; Char and Christensen 1980; Denslow and Kielar 
1978) and with primary malignant melanoma of the uveal 
tract (Michelson etal. 1976a, 1977; Breborowicz etal. 
1978). Pathological plasma CEA concentrations, which ap- 
pear to decrease in the course of treatment, have also been 
observed in some patients with retinoblastoma (Michelson 
etal. 1976b; Gerke etal. 1978; Minoda etal. 1981). In 
asymptomatic relatives of retinoblastoma p tients plasma 
CEA titre may he elevated more often than normal (Felberg 
et al. 1976). It has been suggested that determinations of
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CEA be used in monitoring the therapy of patients with 
retinoblastoma (Michelson et al. 1976 b). 
The measurements of CEA in plasma can be considered 
reliable only when the associated tumour has been shown 
to produce CEA. Thus, we became interested in possible 
observations of the production of CEA by retinoblastoma. 
Only Michelson et al. (1976b) have conducted such a study 
and they were unable to find CEA in retinoblastoma tissue. 
After their work, Hsu et al. (1981 a and b) have described 
a new immunohistochemical st ining method based on the 
strong interaction between avidin and biotin. The sensitivity 
of this method is up to 40-fold compared with the peroxi- 
dase-antiperoxidase m thod formerly considered to be the 
most sensitive one (DeLellis et al. 1979). The purpose of 
our study was to clarify by this method whether etinoblas- 
toma expresses CEA and thus might be causing the patho- 
logical plasma titres observed. The clarification of this rela- 
tionship is of crucial importance in assessing the benefit 
of CEA determinations i  the follow-up of treatment ofretin- 
oblastoma patients. 
Material and methods 
Histological specimens. In the Ophthalmic Pathology Labo- 
ratory, Department of Ophthalmology, Helsinki University 
Central Hospital, 59 retinoblastoma specimens from 52 pa- 
tients have been examined in the years 1962-1982. Some 
of these specimens had already been fully sectioned, or sent 
from other hospitals as paraffin sections, but in 47 cases 
(44 patients) the formalin-fixed paraffin-embedded tissue 
specimen was still available. According to the information 
received by the pathologist, 63.6% (28 patients) of these 
retinoblastomata were unilateral and 36.4% (16 patients) 
bilateral. The specimen was an enucleated globe except in 
one case which represented an orbital recurrence. Sections 
(5 l~m-thick) were cut from the specimens and mounted with 
egg white on glass slides. 
For controls, docent Torsten Wahlstr6m kindly sup- 
plied 4-gm-thick paraffin sections from two adenocarcino- 
mata of the colon both known to be CEA-positive. 
Immunohistoehemieal staining. The immunohistochemical 
staining for CEA was carried out using a commercial ver- 
sion (Vectastain ABC Kit, Rabbit IgG, Vector Laborato- 
ries, Burlingame, CA 94010) of the avidin-biotinylated per- 
oxidase complex (ABC) method of Hsu et al. (1981 a and 
b). The staining was done as kindly instructed by docent 
Table 1. Outline of the Vectastain ABC Kit immunoperoxidase 
method for demonstrating CEA in paraffin sections as used in 
this study. MC=moist chamber, T=temperature 37 °C. See text 
for details 
1. Xylene 
2. Graded ethanol series 
3. Methanol /00.0 ml 30 min Perhydrol 1.6 ml 
4. PBS 3 x 10 min 
5. Normal goat serum 30 rain MC 
6. Primary antiserum 60 rain MCT 
7. PBS 3 x 10 rain 
8. Secondary antiserum 30 min MCT 
9. PBS 3 x 10 min 
10. Avidin-biotinylated peroxi- 30 min MCT 
dase complex 
11. PBS 3 x 10 min 
12. Sodium acetate 35.2 ml 
Acetic acid •4.8 ml 
Distilled water 50.0 ml 
Distilled water 100.0 ml 
3-amino-9-ethyl-carbazole 40.0 mg 20 rain 
N,N-dimethyl-formamide 12.0 ml 
Perhydrol 200.0 ~tl 
13. Running tap water 5 min 
14. Kaiser's glyceryl gelatin 
Torsten Wahlstr6m and it is schematically presented in Ta- 
ble 1. 
The sections were heated to the melting point of paraffin 
and deparaffinized in xylene and graded ethanol series. Pos- 
sible endogenous peroxidase activity was destroyed by 
treating the sections for 30 min in a solution containing 
100.0 ml methanol and 1.6 ml 30% hydrogen peroxide (Per- 
hydrol, .E. Merck, Darmstadt). They were then washed for 
three 10-min changes in phosphate-buffered saline (PBS, 
pH 7.4). To reduce the non-immunologic binding of the 
primary antiserum, the sections were incubated with normal 
goat serum (Vectastain ABC Kit, diluted 1:50 with PBS) 
in a moist chamber for 30 min at room temperature. 
The primary antiserum used was commercial (Rabbit 
Antihuman Carcinoembryonic Antigen All5, Lot 069A, 
DAKO Immunoglobulins a/s, Copenhagen), and it had 
been produced in rabbit against CEA purified from hepatic 
metastasis from an adenocarcinoma of the human colon, 
and absorbed with normal human serum as well as blood 
group antigens A, B and 0. In a preliminary staining, the 
best result was obtained by diluting the antiserum / : 1000 
with PBS, to which normal goat serum had been added 
1:100 to prevent adsorption on glass surfaces. The sections 
were incubated in duplicate in a moist chamber at 37°C 
for 60 min, using the dilutions 1:/00 and 1:1000 of the 
primary antiserum, and washed in PBS. 
The biotinylated secondary antiserum directed against 
rabbit immunoglobulins had been produced in goat (Vec- 
tastain ABC Kit, diluted 1:250 with PBS) and the incuba- 
tion was carried out for 30 min as mentioned above. During 
the following PBS washing, ABC complex was prepared 
by pipetting 5.0 gl Reagent A (Avidin DH, Vectastain ABC 
Kit) and 5.0 gl Reagent B (Biotinylated Horse-radish Per- 
oxidase, Vectastain ABC Kit) for every 0.8 ml PBS buffer 
and mixing thoroughly. The sections were incubated as de- 
scribed above for 30 min and washed in PBS. With avidin 
acting as a bridge, the biotinylated secondary antibody 
bound the peroxidase molecules in the ABC complex to 
the antigen site. 
A buffer consisting of 35.2 ml 0.2 M sodium acetate, 
14.8 ml 0.2 M acetic acid and 50.0 ml distilled water was 
prepared for the staining solution and titrated to pH 5.0 
with sodium hydroxide, whereafter an additional 100.0 ml 
distilled water was added. The staining solution was acti- 
vated by adding 40.0 mg 3-amino-9-ethylcarbazole (Sigma 
Chemical Company, St. Louis, Mo. 63178) dissolved in 
/2.0 ml N,N-dimethylformamide (Uvasol, E. Merck, 
Darmstadt) and 200.0 gl 30% hydrogen peroxide. The sec- 
tions were stained for 20 rain at room temperature, rinsed 
in running tap water for 5 min, and the cover-slips mounted 
with Kaiser's glyceryl gelatin. No counter-staining was 
used. 
Results 
Histopathological examination. In sections tained with hae- 
matoxylin and eosin, 52.2% of the retinoblastomata formed 
distinct Flexner-Wintersteiner rosettes and could be classi- 
fied as differentiated (Table 2; Zimmerman 1980). The bi- 
lateral retinoblastomata were more often differentiated 
than the unilateral turnouts. Of the retinoblastomata 21.7% 
infiltrated into the choroid and 10.9% grew into the optic 
nerve. The unilateral tumours infiltrated into the choroid 
more often than the bilateral ones, whereas invasion of 
the optic nerve was equally common for both types. 
Immunohistochemical st ining. The known colon adenocar- 
cinomata controls howed strong positive reaction for CEA 
with the 1 : 100 and 1 :/000 dilutions of the primary antise- 
rum. Staining was localized to the surface and the cyto- 
plasm of the adenoid cells as well as to the luminal material. 
With the 1 : 100 dilution of antiserum, background staining 
was significant. Omitting any one step in the staining proce- 
dure resulted in a negative reaction. 
All of the 47 retinoblastomata examined showed nega- 
tive staining for CEA. However, in almost all tumours iso- 
lated cells with positive staining were found, due to non- 
specific reaction. Additionally, collagen of the sclera, ne- 
crotic areas in the turnout and subretinal fluid could give 
diffuse positive reactions because of non-specific binding, 
but the colour reaction was slight. In the limbal region, 
the corneoconjunctival epithelial cells regularly showed 
strong positive staining with the 1 :/000 dilution of the pri- 
Table 2. Distribution of the intraocular retinoblastomata examined 
into different clinicopathological groups 
Total Uni- Bi- 
lateral lateral 
Flexner-Wintersteiner rosettes 52.2% 42.9% 66.7% 
Infiltration into the choroid 21.7% 28.6% 11.1% 
Infiltration into the optic nerve 10.9% 10.7% 11.1% 
N=46 N=28 N=I8 
10 
mary antiserum. The colour reaction was mainly localized 
to the older surface cells. There were no differences in the 
stainability between the 1 : 100 and 1 : 1000 dilutions. 
Discussion 
Three research groups have independently shown that in 
some patients with retinoblastoma the concentration of car- 
cinoembryonic antigen in plasma has been elevated to patho- 
logical levels (Michelson et al. 1976b; Gerke et al. 1978; 
Minoda et al. 1981). In all these studies, the average CEA 
titre was also noted to decrease in the patients treated. Thus, 
plasma CEA titre behaved in the same way as in patients 
with adenocarcinoma of the colon (yon Kleist 1977; Anony- 
mous 1981). In clinical practice a pre-operatively elevated 
CEA titre has generally been considered reliable (Anony- 
mous 1981). Slightly elevated plasma concentrations are not 
significant, because CEA titres ranging from 2.5-5.0 ng/ml 
are also related to many benign disorders (Loewenstein and 
Zamcheck 1978; Anonymous 1981). It should be noted, 
however, that determinations of plasma CEA titre are reli- 
able only when the associated tumour has been shown to 
be positive for CEA (Goldenberg et al. 1976). 
In the present study, we were unable to demonstrate 
CEA in the 47 retinoblastomata examined. The material 
was unselected and representative of the clinical and patho- 
logical forms of retinoblastoma. Presumably the inheritance 
of  all bilateral retinoblastomata (36.4%) was autosomally 
dominant, and some of the unilateral cases have also to 
be considered hereditary (Vogel 1979). Of the retinoblasto- 
mata 52.2% was differentiated and formed Flexner-Winter- 
steiner rosettes, 21.7% infiltrated into the choroid and 
10.9% into the optic nerve. These clinical and pathological 
variables had no correlation to stainability for CEA. 
Our observations agree with those of Michelson et al. 
(1976b) who stained 17 retinoblastomata by the immuno- 
histochemical peroxidase-antiperoxidase m thod, consid- 
ered to be somewhat more insensitive than the ABC method 
we used (Hsu et al. 1981 a and b). Though a pre-operatively 
elevated plasma CEA titre was related to at least four of 
these tumours, all showed negative staining. Michelson 
et al. (1976b) also approached this problem by culturing 
cells in vitro from three CEA-associated retinoblastomata 
and from retinoblastoma cell line Y 79 (Reid et al. 1974). 
CEA was not radioimlnunologically demonstrable in the 
tissue culture medium. Furthermore, the workers grew re- 
tinoblastoma cells in the anterior chamber of a rabbit eye. 
CEA was not demonstrable in the rabbit blood circulation, 
even though the tumour had metastasized to the lungs and 
the liver. Our results together with these observations lean 
strongly towards the theory that retinoblastoma does not 
express carcinoembryonic antigen. They do not, however, 
agree with the observations mentioned above, according 
to which retinoblastoma c n be associated with a pathologi- 
cal CEA titre in plasma (Michelson et al. 1976b; Gerke 
et al. 1978; Minoda et al. 1981). 
We believe that this controversy cannot be due to the 
methods used (Table 3). The avidin-biotinylated peroxidase 
staining method can be concluded to be at present he most 
sensitive means to demonstrate antigenic structures in for- 
malin-fixed paraffin-embedded tissue sections (DeLellis 
et al. 1979; Hsu et al. 1981a and b). Some deterioration 
of antigenic activity is always related to formalin fixation, 
but the high sensitivity of the current immunoperoxidase 
Table 3. Different models for explaining the relationship between 
retinoblastoma and carcinoembryonic antigen 
Presuming retinoblastoma produces CEA 
1. The method of demonstration is too insensitive 
2. CEA is destroyed uring tissue preparation 
3. Difficulties due to immunologic heterogeneity of CEA and anti- 
sera 
4. CEA is covered by some other structure 
Presuming retinoblastoma c uses elevated plasma CEA titres indi- 
rectly 
1. Synthesis of CEA elsewhere in the body is induced by: inter- 
feron; unknown factor 
2. CEA metabolism is transformed 
3. CEA production by tumours associated to hereditary retinoblas- 
toma 
Presuming retinoblastoma is a phenomenon separate from elevated 
plasma CEA titres 
1. Plasma CEA titres are physiologically higher in children than 
in adults 
2. Plasma CEA titre elevated ue to some other intercurrent dis- 
order 
methods compensates for this loss (DeLellis et al. 1979). 
Moreover, CEA is resistant at least to fixation in 10% for- 
malin, and CEA activity may be retained for up to 35 years 
in formalin-fixed paraffin-embedded tissue (Harrowe and 
Taylor 1981). Differences between anti-CEA sera have been 
regarded as an important factor in CEA research (Tomita 
et al. 1974; Vrba et al. 1975). In our study, we used a known 
commercial primary antiserum which we, against he manu- 
facturer's instructions, did not absorb with corresponding 
normal tissue. Thus, a false-positive result could be consid- 
ered much more likely than a false-negative r sult. Michel- 
son et al. (1976 b) have excluded the possibility of a blocking 
CEA autoantibody. I f CEA is present in retinoblastoma 
its amount has to be very small. Considering the inevitably 
small volume and the intraocular localization of  retinoblas- 
toma, it appears very unlikely that it could directly cause 
the pathological plasma CEA titres. 
There are, however, various other possibilities to explain 
the well-documented association between retinoblastoma 
and pathological plasma CEA levels (Table 3), though at 
the moment none of these theories can be considered prefer- 
able to the others. On the basis of our own observations 
and those of Michelson et al. (1976b) we must question 
the value of plasma CEA determinations in monitoring the 
treatment of patients with retinoblastoma until a more thor- 
ough knowledge of the tumour-CEA relationship has been 
achieved. In particular, further research is required into 
the normal distribution of plasma CEA titres in healthy 
children. 
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